1 Study Coverage 1.1 Anticoagulant Product Introduction 1.2 Market Segments 1.3 Key Anticoagulant Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Anticoagulant Market Size Growth Rate by Type 1.4.2 Oral 1.4.3 Injectable 1.5 Market by Application 1.5.1 Global Anticoagulant Market Size Growth Rate by Application 1.5.2 DVT 1.5.3 PE 1.5.4 AF 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Anticoagulant Market Size, Estimates and Forecasts 2.1.1 Global Anticoagulant Revenue 2015-2026 2.1.2 Global Anticoagulant Sales 2015-2026 2.2 Global Anticoagulant, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Anticoagulant Historical Market Size by Region (2015-2020) 2.3.1 Global Anticoagulant Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Anticoagulant Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Anticoagulant Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Anticoagulant Sales Forecast by Region (2021-2026) 2.4.2 Global Anticoagulant Revenue Forecast by Region (2021-2026) 3 Global Anticoagulant Competitor Landscape by Players 3.1 Global Top Anticoagulant Sales by Manufacturers 3.1.1 Global Anticoagulant Sales by Manufacturers (2015-2020) 3.1.2 Global Anticoagulant Sales Market Share by Manufacturers (2015-2020) 3.2 Global Anticoagulant Manufacturers by Revenue 3.2.1 Global Anticoagulant Revenue by Manufacturers (2015-2020) 3.2.2 Global Anticoagulant Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Anticoagulant Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Anticoagulant Revenue in 2019 3.2.5 Global Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Anticoagulant Price by Manufacturers 3.4 Global Anticoagulant Manufacturing Base Distribution, Product Types 3.4.1 Anticoagulant Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Anticoagulant Product Type 3.4.3 Date of International Manufacturers Enter into Anticoagulant Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Anticoagulant Market Size by Type (2015-2020) 4.1.1 Global Anticoagulant Sales by Type (2015-2020) 4.1.2 Global Anticoagulant Revenue by Type (2015-2020) 4.1.3 Anticoagulant Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Anticoagulant Market Size Forecast by Type (2021-2026) 4.2.1 Global Anticoagulant Sales Forecast by Type (2021-2026) 4.2.2 Global Anticoagulant Revenue Forecast by Type (2021-2026) 4.2.3 Anticoagulant Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Anticoagulant Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Anticoagulant Market Size by Application (2015-2020) 5.1.1 Global Anticoagulant Sales by Application (2015-2020) 5.1.2 Global Anticoagulant Revenue by Application (2015-2020) 5.1.3 Anticoagulant Price by Application (2015-2020) 5.2 Anticoagulant Market Size Forecast by Application (2021-2026) 5.2.1 Global Anticoagulant Sales Forecast by Application (2021-2026) 5.2.2 Global Anticoagulant Revenue Forecast by Application (2021-2026) 5.2.3 Global Anticoagulant Price Forecast by Application (2021-2026) 6 United States by Players, Type and Application 6.1 United States Anticoagulant Market Size YoY Growth 2015-2026 6.1.1 United States Anticoagulant Sales YoY Growth 2015-2026 6.1.2 United States Anticoagulant Revenue YoY Growth 2015-2026 6.1.3 United States Anticoagulant Market Share in Global Market 2015-2026 6.2 United States Anticoagulant Market Size by Players (International and Local Players) 6.2.1 United States Top Anticoagulant Players by Sales (2015-2020) 6.2.2 United States Top Anticoagulant Players by Revenue (2015-2020) 6.3 United States Anticoagulant Historic Market Review by Type (2015-2020) 6.3.1 United States Anticoagulant Sales Market Share by Type (2015-2020) 6.3.2 United States Anticoagulant Revenue Market Share by Type (2015-2020) 6.3.3 United States Anticoagulant Price by Type (2015-2020) 6.4 United States Anticoagulant Market Estimates and Forecasts by Type (2021-2026) 6.4.1 United States Anticoagulant Sales Forecast by Type (2021-2026) 6.4.2 United States Anticoagulant Revenue Forecast by Type (2021-2026) 6.4.3 United States Anticoagulant Price Forecast by Type (2021-2026) 6.5 United States Anticoagulant Historic Market Review by Application (2015-2020) 6.5.1 United States Anticoagulant Sales Market Share by Application (2015-2020) 6.5.2 United States Anticoagulant Revenue Market Share by Application (2015-2020) 6.5.3 United States Anticoagulant Price by Application (2015-2020) 6.6 United States Anticoagulant Market Estimates and Forecasts by Application (2021-2026) 6.6.1 United States Anticoagulant Sales Forecast by Application (2021-2026) 6.6.2 United States Anticoagulant Revenue Forecast by Application (2021-2026) 6.6.3 United States Anticoagulant Price Forecast by Application (2021-2026) 7 North America 7.1 North America Anticoagulant Market Size YoY Growth 2015-2026 7.2 North America Anticoagulant Market Facts & Figures by Country 7.2.1 North America Anticoagulant Sales by Country (2015-2020) 7.2.2 North America Anticoagulant Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Anticoagulant Market Size YoY Growth 2015-2026 8.2 Europe Anticoagulant Market Facts & Figures by Country 8.2.1 Europe Anticoagulant Sales by Country 8.2.2 Europe Anticoagulant Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Anticoagulant Market Size YoY Growth 2015-2026 9.2 Asia Pacific Anticoagulant Market Facts & Figures by Country 9.2.1 Asia Pacific Anticoagulant Sales by Region (2015-2020) 9.2.2 Asia Pacific Anticoagulant Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Anticoagulant Market Size YoY Growth 2015-2026 10.2 Latin America Anticoagulant Market Facts & Figures by Country 10.2.1 Latin America Anticoagulant Sales by Country 10.2.2 Latin America Anticoagulant Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Anticoagulant Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Anticoagulant Market Facts & Figures by Country 11.2.1 Middle East and Africa Anticoagulant Sales by Country 11.2.2 Middle East and Africa Anticoagulant Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Bayer 12.1.1 Bayer Corporation Information 12.1.2 Bayer Description and Business Overview 12.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Bayer Anticoagulant Products Offered 12.1.5 Bayer Recent Development 12.2 Boehringer Ingelheim 12.2.1 Boehringer Ingelheim Corporation Information 12.2.2 Boehringer Ingelheim Description and Business Overview 12.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Boehringer Ingelheim Anticoagulant Products Offered 12.2.5 Boehringer Ingelheim Recent Development 12.3 Bristol-Myers Squibb 12.3.1 Bristol-Myers Squibb Corporation Information 12.3.2 Bristol-Myers Squibb Description and Business Overview 12.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Bristol-Myers Squibb Anticoagulant Products Offered 12.3.5 Bristol-Myers Squibb Recent Development 12.4 Daiichi Sankyo 12.4.1 Daiichi Sankyo Corporation Information 12.4.2 Daiichi Sankyo Description and Business Overview 12.4.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Daiichi Sankyo Anticoagulant Products Offered 12.4.5 Daiichi Sankyo Recent Development 12.5 Pfizer 12.5.1 Pfizer Corporation Information 12.5.2 Pfizer Description and Business Overview 12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Pfizer Anticoagulant Products Offered 12.5.5 Pfizer Recent Development 12.6 Johnson & Johnson 12.6.1 Johnson & Johnson Corporation Information 12.6.2 Johnson & Johnson Description and Business Overview 12.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Johnson & Johnson Anticoagulant Products Offered 12.6.5 Johnson & Johnson Recent Development 12.7 Sanofi 12.7.1 Sanofi Corporation Information 12.7.2 Sanofi Description and Business Overview 12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Sanofi Anticoagulant Products Offered 12.7.5 Sanofi Recent Development 12.8 AstraZeneca 12.8.1 AstraZeneca Corporation Information 12.8.2 AstraZeneca Description and Business Overview 12.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020) 12.8.4 AstraZeneca Anticoagulant Products Offered 12.8.5 AstraZeneca Recent Development 12.9 Eli Lilly 12.9.1 Eli Lilly Corporation Information 12.9.2 Eli Lilly Description and Business Overview 12.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Eli Lilly Anticoagulant Products Offered 12.9.5 Eli Lilly Recent Development 12.10 Keryx Biopharmaceuticals 12.10.1 Keryx Biopharmaceuticals Corporation Information 12.10.2 Keryx Biopharmaceuticals Description and Business Overview 12.10.3 Keryx Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Keryx Biopharmaceuticals Anticoagulant Products Offered 12.10.5 Keryx Biopharmaceuticals Recent Development 12.11 Bayer 12.11.1 Bayer Corporation Information 12.11.2 Bayer Description and Business Overview 12.11.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Bayer Anticoagulant Products Offered 12.11.5 Bayer Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Anticoagulant Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Anticoagulant Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Anticoagulant Market Segments Table 2. Ranking of Global Top Anticoagulant Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Anticoagulant Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Oral Table 5. Major Manufacturers of Injectable Table 6. Global Anticoagulant Market Size Growth Rate by Application 2020-2026 (K Units) Table 7. Global Anticoagulant Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 8. Global Anticoagulant Sales by Regions 2015-2020 (K Units) Table 9. Global Anticoagulant Sales Market Share by Regions (2015-2020) Table 10. Global Anticoagulant Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Anticoagulant Sales Forecast by Region (2021-2026) (K Units) Table 12. Global Anticoagulant Sales by Manufacturers (2015-2020) (K Units) Table 13. Global Anticoagulant Sales Share by Manufacturers (2015-2020) Table 14. Global Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 15. Global Anticoagulant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant as of 2019) Table 16. Anticoagulant Revenue by Manufacturers (2015-2020) (US$ Million) Table 17. Anticoagulant Revenue Share by Manufacturers (2015-2020) Table 18. Key Manufacturers Anticoagulant Price (2015-2020) (USD/Unit) Table 19. Anticoagulant Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Anticoagulant Product Type Table 21. Date of International Manufacturers Enter into Anticoagulant Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Global Anticoagulant Sales by Type (2015-2020) (K Units) Table 24. Global Anticoagulant Sales Share by Type (2015-2020) Table 25. Global Anticoagulant Revenue by Type (2015-2020) (US$ Million) Table 26. Global Anticoagulant Revenue Share by Type (2015-2020) Table 27. Anticoagulant Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 28. Global Anticoagulant Sales Share by Type (2021-2026) Table 29. Global Anticoagulant Sales by Application (2015-2020) (K Units) Table 30. Global Anticoagulant Sales Share by Application (2015-2020) Table 31. Global Anticoagulant Sales Share by Application (2021-2026) Table 32. Global Anticoagulant Sales Market Share Forecast by Application (2021-2026) Table 33. Global Anticoagulant Revenue by Application (2015-2020) (US$ Million) Table 34. Global Anticoagulant Revenue Market Share Forecast by Application (2021-2026) Table 35. United States Anticoagulant Sales (K Units) of Key Companies (2015-2020) Table 36. United States Anticoagulant Sales Share by Company (2015-2020) Table 37. United States Anticoagulant Revenue (US$ Million) by Company (2015-2020) Table 38. United States Anticoagulant Sales (K Units) by Type (2015-2020) Table 39. United States Anticoagulant Sales Share by Type (2015-2020) Table 40. United States Anticoagulant Revenue (US$ Million) Market Share by Type (2015-2020) Table 41. United States Anticoagulant Price (K Units) by Type (2015-2020) Table 42. United States Anticoagulant Sales (K Units) by Type (2021-2026) Table 43. United States Anticoagulant Sales Share by Type (2021-2026) Table 44. United States Anticoagulant Revenue (US$ Million) Market Share by Type (2021-2026) Table 45. United States Anticoagulant Revenue Share by Type (2021-2026) Table 46. United States Anticoagulant Price (K Units) by Type (2021-2026) Table 47. United States Anticoagulant Sales (K Units) by Application (2015-2020) Table 48. United States Anticoagulant Sales Share by Application (2015-2020) Table 49. United States Anticoagulant Revenue (US$ Million) Market Share by Application (2015-2020) Table 50. United States Anticoagulant Sales (K Units) by Application (2021-2026) Table 51. United States Anticoagulant Sales Share by Application (2021-2026) Table 52. United States Anticoagulant Revenue (US$ Million) Market Share by Application (2021-2026) Table 53. United States Anticoagulant Revenue Share by Application (2021-2026) Table 54. North America Anticoagulant Sales by Country (2015-2020) (K Units) Table 55. North America Anticoagulant Sales Market Share by Country (2015-2020) Table 56. North America Anticoagulant Revenue by Country (2015-2020) (US$ Million) Table 57. North America Anticoagulant Revenue Market Share by Country (2015-2020) Table 58. Europe Anticoagulant Sales by Country (2015-2020) (K Units) Table 59. Europe Anticoagulant Sales Market Share by Country (2015-2020) Table 60. Europe Anticoagulant Revenue by Country (2015-2020) (US$ Million) Table 61. Europe Anticoagulant Revenue Market Share by Country (2015-2020) Table 62. Asia Pacific Anticoagulant Sales by Region (2015-2020) (K Units) Table 63. Asia Pacific Anticoagulant Sales Market Share by Region (2015-2020) Table 64. Asia Pacific Anticoagulant Revenue by Region (2015-2020) (US$ Million) Table 65. Asia Pacific Anticoagulant Revenue Market Share by Region (2015-2020) Table 66. Latin America Anticoagulant Sales by Country (2015-2020) (K Units) Table 67. Latin America Anticoagulant Sales Market Share by Country (2015-2020) Table 68. Latin Americaa Anticoagulant Revenue by Country (2015-2020) (US$ Million) Table 69. Latin America Anticoagulant Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Anticoagulant Sales by Country (2015-2020) (K Units) Table 71. Middle East and Africa Anticoagulant Sales Market Share by Country (2015-2020) Table 72. Middle East and Africa Anticoagulant Revenue by Country (2015-2020) (US$ Million) Table 73. Middle East and Africa Anticoagulant Revenue Market Share by Country (2015-2020) Table 74. Bayer Corporation Information Table 75. Bayer Description and Business Overview Table 76. Bayer Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 77. Bayer Anticoagulant Product Table 78. Bayer Recent Development Table 79. Boehringer Ingelheim Corporation Information Table 80. Boehringer Ingelheim Description and Business Overview Table 81. Boehringer Ingelheim Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 82. Boehringer Ingelheim Product Table 83. Boehringer Ingelheim Recent Development Table 84. Bristol-Myers Squibb Corporation Information Table 85. Bristol-Myers Squibb Description and Business Overview Table 86. Bristol-Myers Squibb Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 87. Bristol-Myers Squibb Product Table 88. Bristol-Myers Squibb Recent Development Table 89. Daiichi Sankyo Corporation Information Table 90. Daiichi Sankyo Description and Business Overview Table 91. Daiichi Sankyo Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 92. Daiichi Sankyo Product Table 93. Daiichi Sankyo Recent Development Table 94. Pfizer Corporation Information Table 95. Pfizer Description and Business Overview Table 96. Pfizer Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 97. Pfizer Product Table 98. Pfizer Recent Development Table 99. Johnson & Johnson Corporation Information Table 100. Johnson & Johnson Description and Business Overview Table 101. Johnson & Johnson Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 102. Johnson & Johnson Product Table 103. Johnson & Johnson Recent Development Table 104. Sanofi Corporation Information Table 105. Sanofi Description and Business Overview Table 106. Sanofi Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 107. Sanofi Product Table 108. Sanofi Recent Development Table 109. AstraZeneca Corporation Information Table 110. AstraZeneca Description and Business Overview Table 111. AstraZeneca Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 112. AstraZeneca Product Table 113. AstraZeneca Recent Development Table 114. Eli Lilly Corporation Information Table 115. Eli Lilly Description and Business Overview Table 116. Eli Lilly Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 117. Eli Lilly Product Table 118. Eli Lilly Recent Development Table 119. Keryx Biopharmaceuticals Corporation Information Table 120. Keryx Biopharmaceuticals Description and Business Overview Table 121. Keryx Biopharmaceuticals Anticoagulant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 122. Keryx Biopharmaceuticals Product Table 123. Keryx Biopharmaceuticals Recent Development Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 125. Key Challenges Table 126. Market Risks Table 127. Main Points Interviewed from Key Anticoagulant Players Table 128. Anticoagulant Customers List Table 129. Anticoagulant Distributors List Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Anticoagulant Product Picture Figure 2. Global Anticoagulant Sales Market Share by Type in 2020 & 2026 Figure 3. Oral Product Picture Figure 4. Injectable Product Picture Figure 5. Global Anticoagulant Sales Market Share by Application in 2020 & 2026 Figure 6. DVT Figure 7. PE Figure 8. AF Figure 9. Anticoagulant Report Years Considered Figure 10. Global Anticoagulant Market Size 2015-2026 (US$ Million) Figure 11. Global Anticoagulant Sales 2015-2026 (K Units) Figure 12. Global Anticoagulant Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Anticoagulant Sales Market Share by Region (2015-2020) Figure 14. Global Anticoagulant Sales Market Share by Region in 2019 Figure 15. Global Anticoagulant Revenue Market Share by Region (2015-2020) Figure 16. Global Anticoagulant Revenue Market Share by Region in 2019 Figure 17. Global Anticoagulant Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Anticoagulant Revenue in 2019 Figure 19. Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Anticoagulant Sales Market Share by Type (2015-2020) Figure 21. Global Anticoagulant Sales Market Share by Type in 2019 Figure 22. Global Anticoagulant Revenue Market Share by Type (2015-2020) Figure 23. Global Anticoagulant Revenue Market Share by Type in 2019 Figure 24. Global Anticoagulant Market Share by Price Range (2015-2020) Figure 25. Global Anticoagulant Sales Market Share by Application (2015-2020) Figure 26. Global Anticoagulant Sales Market Share by Application in 2019 Figure 27. Global Anticoagulant Revenue Market Share by Application (2015-2020) Figure 28. Global Anticoagulant Revenue Market Share by Application in 2019 Figure 29. United States Anticoagulant Sales Growth Rate 2015-2026 (K Units) Figure 30. United States Anticoagulant Revenue Growth Rate 2015-2026 (US$ Million) Figure 31. United States Anticoagulant Market Share in Global Market 2015-2026 Figure 32. United States 5 and 10 Largest Anticoagulant Players Market Share by Revenue in Anticoagulant in 2019 Figure 33. United States Anticoagulant Revenue Share by Type (2015-2020) Figure 34. United States Anticoagulant Revenue Growth Rate by Type in 2015 & 2019 Figure 35. United States Anticoagulant Revenue Share by Application (2015-2020) Figure 36. United States Anticoagulant Revenue Growth Rate by Application in 2015 & 2019 Figure 37. North America Anticoagulant Sales Growth Rate 2015-2020 (K Units) Figure 38. North America Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million) Figure 39. North America Anticoagulant Sales Market Share by Country in 2019 Figure 40. North America Anticoagulant Revenue Market Share by Country in 2019 Figure 41. U.S. Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 42. U.S. Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Canada Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 44. Canada Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Europe Anticoagulant Sales Growth Rate 2015-2020 (K Units) Figure 46. Europe Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million) Figure 47. Europe Anticoagulant Sales Market Share by Country in 2019 Figure 48. Europe Anticoagulant Revenue Market Share by Country in 2019 Figure 49. Germany Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 50. Germany Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. France Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 52. France Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. U.K. Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 54. U.K. Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Italy Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 56. Italy Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Russia Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 58. Russia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Asia Pacific Anticoagulant Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Anticoagulant Sales Market Share by Region in 2019 Figure 62. Asia Pacific Anticoagulant Revenue Market Share by Region in 2019 Figure 63. China Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 64. China Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 70. India Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Latin America Anticoagulant Sales Growth Rate 2015-2020 (K Units) Figure 86. Latin America Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Anticoagulant Sales Market Share by Country in 2019 Figure 88. Latin America Anticoagulant Revenue Market Share by Country in 2019 Figure 89. Mexico Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 90. Mexico Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 92. Brazil Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 94. Argentina Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Middle East and Africa Anticoagulant Sales Growth Rate 2015-2020 (K Units) Figure 96. Middle East and Africa Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Anticoagulant Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Anticoagulant Revenue Market Share by Country in 2019 Figure 99. Turkey Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 100. Turkey Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 102. Saudi Arabia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Anticoagulant Sales Growth Rate (2015-2020) (K Units) Figure 104. U.A.E Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Porter's Five Forces Analysis Figure 106. Anticoagulant Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Bayer Boehringer Ingelheim Bristol-Myers Squibb Daiichi Sankyo Pfizer Johnson & Johnson Sanofi AstraZeneca Eli Lilly Keryx Biopharmaceuticals